Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Aetna

Aetna

Jan 08, 2020

CVS Health, Tempus Precision Oncology Program Aims to Aid Oncologists, Improve Patient Outcomes

Premium

The CVS-Tempus partnership aims to streamline the cancer care process for patients from the point of prescribing onwards and connect patients with local trials.

Nov 08, 2019

Some Call for Expanded Payor Coverage of NIPS but Reluctance Remains

Premium

A preliminary analysis lends some support to covering NIPS for pregnancies beyond high-risk, and some payors have expanded coverage.  

 

Jul 18, 2017

Castle Biosciences Uveal Melanoma Prognostic Test Garners Coverage from Multiple Payors

The company announced positive coverage decisions from Palmetto GBA, 14 BCBS plans, and Aetna.

Feb 09, 2017

Aetna to Cover NxGen MDx Genetic Testing Services

Starting Feb. 15, Aetna members will be able to access NxGen MDx's genetic screening and noninvasive prenatal testing as an in-network benefit. 

Jan 04, 2017

GenomeWeb Index Falls 3 Percent in 2016; Genmark Leads Gainers as PacBio Drops

It was a rough year for biotech stocks — the Nasdaq Biotech Index fell 22 percent even as the Dow gained 13 percent and the Nasdaq gained 8 percent.

Dec 08, 2016

Aetna, Interpace Diagnostics Ink Coverage Agreement for Thyroid Assay

The new agreement brings Interpace's total insurance coverage for its thyroid assays to approximately 200 million patients.

Jun 26, 2015

Veracyte Thyroid Cancer Test Added to Aetna's Laboratory Network

The test differentiates benign thyroid nodules from cancerous ones.

Jul 07, 2014

Aetna Begins Coverage of CardioDx's Coronary Artery Disease Test

NEW YORK (GenomeWeb) – CardioDx today announced that Aetna has established a clinical policy for the Corus CAD gene expression test for coronary artery disease.

Apr 04, 2014

Aetna Policy Bulletin Indicates Insurer Unlikely to Cover Most Proteomic Cancer Tests

Premium

Insurer Aetna last month released a clinical policy bulletin providing an assessment of various available molecular-based cancer diagnostics and markers.

Apr 02, 2014

MDx/CDx Focus: 23andMe Still Working with FDA; Aetna Lists Medically Necessary, Investigational Dx

Premium

While Working with FDA, 23andMe Offers Customers No Timeline for Reporting Health-related Results

Pages

The Scan

This Time, Novamax

Novamax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Shortened Visas for Some Students

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

New York's Own Review

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

Science Papers Examine Y Chromosomes of Archaic Humans, Schistosomiasis Therapeutic Targets

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.